Advertisement
U.S. markets closed

Implanet S.A. (IMPZY)

Other OTC - Other OTC Delayed Price. Currency in USD
0.08000.0000 (0.00%)
At close: 03:53PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0800
Open0.0800
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0800 - 0.0800
52 Week Range0.0800 - 0.0800
Volume7,015
Avg. Volume0
Market Cap199.95M
Beta (5Y Monthly)1.22
PE Ratio (TTM)N/A
EPS (TTM)-0.0500
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateFeb 16, 2024
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for IMPZY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • IMPLANET
    Analyst Report: Cisco Systems, Inc.Cisco Systems, Inc. is the world's largest hardware and software supplier within the networking solutions sector. The infrastructure platforms group includes hardware and software products for switching, routing, data center, and wireless applications. Its applications portfolio contains collaboration, analytics, and Internet of Things products. The security segment contains Cisco's firewall and software-defined security products. Services are Cisco's technical support and advanced services offerings. The company’s wide array of hardware is complemented with solutions for software-defined networking, analytics, and intent-based networking. In collaboration with Cisco's initiative on growing software and services, its revenue model is focused on increasing subscriptions and recurring sales.
    Rating
    Fair Value
    Economic Moat
    2 years agoMorningstar
View more
  • Business Wire

    IMPLANET Reports Its 2023 Full-Year Results

    BORDEAUX, France & BOSTON, March 06, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plan), a medical technology company specialized in implants for orthopedic surgery and the distribution of technological medical equipment, today announced its 2023 full-year results, as of December 31, 2023, as approved by the Board of Directors on March 5, 2024.

  • Business Wire

    Implanet Announces the Success of Its Capital Increase

    BORDEAUX, France & BOSTON, February 02, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), (the "Company"), a medical technology company specialized in implants for orthopedic surgery and the distribution of technological medical equipment, announces the success of the capital increase in cash with preferential subscription rights for shareholders announced on January 4, 2024 (the "Capital Increase"). This operation raised €5.5 mill

  • Business Wire

    Implanet Announces the Appointment of Max W. Painter as Vice-President and General Manager of its US Subsidiary

    BORDEAUX, France & BOSTON, January 25, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the distribution of technological medical equipment, announced the appointment of Max W. Painter as VP & General Manager of Implanet America. In this position, he will lead Implanet America, with the aim of optimizing its organizational structure to accelerate the